Financials [ 3/12 ] | Capital Markets [ 42/74 ]
NASDAQ | Common Stock
Drugs Made In America Acquisition Corp. does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses.
Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Sep 30, 25 | 0.07 | - |
| Aug 14, 25 | 0.07 | - |
| May 20, 25 | 0.05 | - |
| Mar 31, 25 | -0.03 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 0.00 Decreased by N/A% | 2.18 M Increased by +1.61 K% | Increased by +N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | 2.29 M Increased by +4.17 M% | Increased by +N/A% - |
| Mar 31, 25 | 0.00 - | 1.25 M - | Increased by +N/A% - |
| Dec 31, 24 | N/A - | -279.00 - | - - |
| Sep 30, 24 | 0.00 - | -144.93 K - | Decreased by N/A% - |
| Jun 30, 24 | N/A - | -54.93 - | - - |